JP2019505500A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505500A5
JP2019505500A5 JP2018532429A JP2018532429A JP2019505500A5 JP 2019505500 A5 JP2019505500 A5 JP 2019505500A5 JP 2018532429 A JP2018532429 A JP 2018532429A JP 2018532429 A JP2018532429 A JP 2018532429A JP 2019505500 A5 JP2019505500 A5 JP 2019505500A5
Authority
JP
Japan
Prior art keywords
hydroxy
carboxamide
benzoxazole
phenyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018532429A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505500A (ja
JP6927589B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/077914 external-priority patent/WO2017108282A1/en
Publication of JP2019505500A publication Critical patent/JP2019505500A/ja
Publication of JP2019505500A5 publication Critical patent/JP2019505500A5/ja
Application granted granted Critical
Publication of JP6927589B2 publication Critical patent/JP6927589B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018532429A 2015-12-22 2016-11-16 哺乳類ヒストンデアセチラーゼ活性の阻害剤として有用な二環式ヒドロキサム酸 Expired - Fee Related JP6927589B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15201841 2015-12-22
EP15201841.2 2015-12-22
PCT/EP2016/077914 WO2017108282A1 (en) 2015-12-22 2016-11-16 Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity

Publications (3)

Publication Number Publication Date
JP2019505500A JP2019505500A (ja) 2019-02-28
JP2019505500A5 true JP2019505500A5 (enExample) 2019-12-19
JP6927589B2 JP6927589B2 (ja) 2021-09-01

Family

ID=55068815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018532429A Expired - Fee Related JP6927589B2 (ja) 2015-12-22 2016-11-16 哺乳類ヒストンデアセチラーゼ活性の阻害剤として有用な二環式ヒドロキサム酸

Country Status (11)

Country Link
US (1) US10654814B2 (enExample)
EP (1) EP3394052B1 (enExample)
JP (1) JP6927589B2 (enExample)
KR (1) KR20180098593A (enExample)
CN (1) CN108602812B (enExample)
AU (1) AU2016375634B2 (enExample)
CA (1) CA3007025A1 (enExample)
ES (1) ES2893099T3 (enExample)
RU (1) RU2747431C2 (enExample)
WO (1) WO2017108282A1 (enExample)
ZA (1) ZA201804568B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7293343B2 (ja) * 2018-05-09 2023-06-19 アプリノイア セラピューティクス リミテッド ヘテロアリール化合物及びその使用
BR112021002165A2 (pt) * 2018-08-06 2021-05-04 The Board Of Trustees Of The Leland Stanford Junior University composto, composição farmacêutica, e, métodos para tratar uma doença neurodegenerativa e deficiência cognitiva associada ao envelhecimento e neuroinflamação
CN112805067A (zh) 2018-08-08 2021-05-14 百时美施贵宝公司 Pad酶的吲哚及氮杂吲哚抑制剂
US11981680B2 (en) 2018-08-08 2024-05-14 Bristol-Myers Squibb Company Substituted thienopyrroles as PAD4 inhibitors
KR102146741B1 (ko) * 2018-10-31 2020-08-21 계명대학교 산학협력단 항바이러스 조성물
AU2019383277A1 (en) * 2018-11-23 2021-06-10 Chong Kun Dang Pharmaceutical Corp. Pharmaceutical composition comprising histone deacetylase 6 inhibitors
EP4076448A4 (en) 2019-12-20 2024-03-27 Tenaya Therapeutics, Inc. Fluoroalkyl-oxadiazoles and uses thereof
TW202140477A (zh) * 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
TWI864293B (zh) * 2020-06-08 2024-12-01 安基生技新藥股份有限公司 選擇性hdac6抑制劑及其用途
CN112516142B (zh) * 2020-12-11 2021-10-15 北京华氏精恒医药科技有限公司 一种具有hdac抑制活性的药物组合物、制备方法及其用途
EP4326263A1 (en) 2021-04-23 2024-02-28 Tenaya Therapeutics, Inc. Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy
EP4333841A1 (en) 2021-05-04 2024-03-13 Tenaya Therapeutics, Inc. 2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef
CN114409638B (zh) * 2022-02-09 2023-02-14 深圳大学 组蛋白去乙酰化酶8选择性降解剂、制备方法及其在抗肿瘤活性中的应用
CA3254742A1 (en) * 2022-03-17 2025-03-04 Sookmyung Women's University Industry-Academic Cooperation Foundation NEW HETEROCYCLIC HISTONE DEACETYLASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION INCLUDING IT
WO2025160629A1 (en) * 2024-01-31 2025-08-07 Certa Therapeutics Pty Ltd Proton sensing gpcr modulators
WO2025215092A1 (en) 2024-04-10 2025-10-16 Institut National de la Santé et de la Recherche Médicale Selective hdac6 inhibitors for use in the treatment of myotonic dystrophy type 1
CN118459418B (zh) * 2024-04-26 2025-04-08 河北中医药大学 一种异羟肟酸类hdac抑制剂及其在制备抗肿瘤药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861533B2 (en) 2001-11-23 2005-03-01 Irm Llc Solution phase sythesis of arylbenzoxazoles
NZ545864A (en) * 2003-09-22 2009-12-24 S Bio Pte Ltd Benzimidazole derivates: preparation and pharmaceutical applications
ZA200602181B (en) * 2003-09-22 2007-06-27 S Bio Pte Ltd Benzimidazole derivatives: Preparation and pharmaceutical applications
WO2005066151A2 (en) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. Histone deacetylase inhibitors
ITFI20050041A1 (it) * 2005-03-15 2006-09-16 Menarini Internat Operations Luxembourg Sa Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
CN101663302B (zh) 2007-04-18 2013-07-24 橘生药品工业株式会社 含氮稠环衍生物、包含所述含氮稠环衍生物的药物组合物及其医药用途
WO2008129276A1 (en) 2007-04-19 2008-10-30 Boehringer Ingelheim International Gmbh Disulfonamides useful in the treatment of inflammation
EP2217588A4 (en) 2007-11-02 2013-12-04 Methylgene Inc INHIBITORS OF HISTONE DEACETYLASE
UA103013C2 (uk) 2007-12-06 2013-09-10 Тиботек Фармасьютикелз Амідні сполуки як активатори противірусних препаратів
CA2875549A1 (en) * 2008-04-15 2009-10-22 Pharmacyclics, Inc. Selective inhibitors of histone deacetylase
WO2010061903A1 (ja) * 2008-11-27 2010-06-03 塩野義製薬株式会社 Pi3k阻害活性を有するピリミジン誘導体およびピリジン誘導体
WO2012012322A1 (en) * 2010-07-19 2012-01-26 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
EP2875007B1 (en) 2012-07-19 2016-08-24 Bristol-Myers Squibb Company Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase
EP3039021A1 (en) 2013-08-30 2016-07-06 Ambit Biosciences Corporation Biaryl acetamide compounds and methods of use thereof
US10287255B2 (en) * 2014-03-12 2019-05-14 Chong Kun Dang Pharmaceutical Corp. Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
EP3152190B1 (en) 2014-06-04 2024-07-31 Haro Pharmaceutical Inc. 18-20 member bi-polycyclic compounds
CA2984971A1 (en) 2015-05-11 2016-11-17 Kancera Ab Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity

Similar Documents

Publication Publication Date Title
JP2019505500A5 (enExample)
RU2747431C2 (ru) Бициклические гидроксамовые кислоты, полезные в качестве ингибиторов активности деацетилазы гистонов млекопитающих
JP7264060B2 (ja) 二環式化合物および癌の処置におけるそれらの使用
KR102781404B1 (ko) 통합 스트레스 경로의 조정제
US10864196B2 (en) Modulators of the integrated stress pathway
JP7307057B2 (ja) 統合的ストレス経路の調節剤
JP6556146B2 (ja) 複素環化合物
US10357484B2 (en) Heterocyclic compound
BR112020008827A2 (pt) moduladores da via de estresse integrada
WO2017033946A1 (ja) 複素環化合物
JPWO2015002230A1 (ja) アミド化合物
CA3090485C (en) Heterobicyclic carboxylic acids for treating cancer or inflammatory diseases
HK40103495A (zh) 用於治疗癌症的杂二环羧酸
HK40029801A (en) Heterobicyclic carboxylic acids for treating cancer or inflammatory diseases
US20200181128A1 (en) 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase